Axa S.A. Vericel Corp Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$15.01 - $18.89 $409,773 - $515,697	-27,300 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$16.23 - $20.29 $115,233 - $144,059	-7,100 Reduced 20.64%	27,300 $478,000
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $370,488 - $634,336	34,400 New	34,400 $599,000

268

48.4M

91.1K

39.8K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.22B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.